Ropharma SA (RPH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Farmaceutica Remedia SA

Ropharma SA

Why is Ropharma SA ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.00%

EBIT Growth (5y)

0.00%

EBIT to Interest (avg)

8.49

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.17

Sales to Capital Employed (avg)

Tax Ratio

21.25%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

8.88%

ROE (avg)

7.04%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.36

EV to EBIT

44.17

EV to EBITDA

EV to Capital Employed

0.49

EV to Sales

0.15

PEG Ratio

0.84

Dividend Yield

ROCE (Latest)

1.10%

ROE (Latest)

3.23%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Ropharma SA

Operating Cash Flow - Annually

Highest at RON 28.90 MM and Grown

each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (RON MM)

Net Sales - Half-Yearly

Highest at RON 520 MM and Grown

in each of the last 5 periods

MOJO Watch

Near term sales trend is very positive

Net Sales (RON MM)

Here's what is not working for Ropharma SA

Profit After Tax (PAT) - Annual

At RON 8.28 MM has Grown at -19.01 %

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very negative

PAT (RON MM)

Operating Profit (PBDIT) - Half-Yearly

Lowest at RON 15 MM.

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (RON MM)

Operating Profit Margin - Half-Yearly

Lowest at 2.87%

in the last five quarters

MOJO Watch

Company's efficiency has deteriorated

Operating Profit to Sales (RON MM)

Profit Before Tax less Other Income (PBT) - Half-Yearly

Lowest at RON 1 MM.

in the last five periods

MOJO Watch

Near term PBT trend is negative

PBT less Other Income (RON MM)

Non Operating Income - Half-Yearly

is 85.54 % of Profit Before Tax (PBT)

MOJO Watch

The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT (RON MM)

Non Operating Income - Half-Yearly

Highest at RON 4 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating Income (RON MM)